Article Text
Abstract
Background Although ageing populations are increasingly residing in cities, it is unknown whether depression inequalities are moderated by urbanicity degree. We estimated gender, marital and educational inequalities in depressive symptoms among older European and Canadian adults, and examined whether higher levels of urbanicity, captured by population density, heightened these inequalities.
Methods Harmonised cross-sectional data on 97 826 adults aged ≥50 years from eight cohorts were used. Prevalence ratios (PRs) were calculated for probable depression, depressed affect and depressive symptom severity by gender, marital status and education within each cohort, and combined using random-effects meta-analysis. Using a subsample of 73 123 adults from six cohorts with available data on population density, we tested moderating effects measured by the number of residents per square kilometre.
Results The pooled PRs for probable depression by female gender, unmarried or non-cohabitating status and low education were 1.48 (95% CI 1.28 to 1.72), 1.44 (95% CI 1.29 to 1.61) and 1.29 (95% CI 1.18 to 1.41), respectively. PRs for depressed affect and high symptom severity were broadly similar. Except for one Dutch cohort with findings in an unexpected direction, there was no evidence that population density modified depressive symptom inequalities.
Conclusions Despite cross-cohort variation in gender, marital status and educational inequalities in depressive symptoms, there was weak evidence that these inequalities differed by levels of population density.
- Ageing
- urbanisation
- social epidemiology
- depression
This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Statistics from Altmetric.com
Footnotes
Contributors MAR co-designed the study, conducted all analyses, drafted the initial and revised manuscript, and approved the final manuscript as submitted. MBo co-designed the study, finalised the initial and revised manuscript, and approved the final manuscript as submitted. BC and FJvL contributed to the design of the study. All coauthors critically reviewed the manuscript and approved the final manuscript as submitted.
Funding This study is supported by a European Commission Horizon 2020 Grant, 667661, as part of the Promoting Mental Well-being in the Ageing Population: Determinants, Policies and Interventions in European Cities (MINDMAP) research project. This research was made possible using the data/biospecimens collected by the Canadian Longitudinal Study on Aging (CLSA). Funding for the CLSA is provided by the Government of Canada through the Canadian Institutes of Health Research (CIHR) under grant reference: LSA 94473 and the Canada Foundation for Innovation. This research has been conducted using the CLSA data set, Baseline Comprehensive Dataset version 4.0, under application number 171013. The CLSA is led by Drs Parminder Raina, Christina Wolfson and Susan Kirkland. The Nord-Trøndelag Health Study (HUNT) is mainly funded by the Norwegian Ministry of Health (NTNU), with additional support from the Norwegian Research Council (the FUGE programme), Central Norway Regional Health Authority, the Nord-Trøndelag County Council and the Norwegian Institute of Public Health. The Health, Alcohol and Psychosocial factors In Eastern Europe (HAPIEE) study is funded by the Wellcome Trust (grants 064947 and 081081), the US National Institute on Aging (grant R01 AG23522-01), the MacArthur Foundation ‘MacArthur Initiative on Social Upheaval and Health’ (grant 712058). The Longitudinal Aging Study Amsterdam (LASA) is largely supported by grants from the Netherlands Ministry of Health, Welfare and Sports, Directorate of Long-Term Care. The Residential Environment and CORonary heart Disease (RECORD) study is supported by INPES (National Institute for Prevention and Health Education); IReSP (Institute for Public Health Research); InVS (National Institute of Public Health Surveillance); French Ministries of Research and Health; CNAM-TS (National Health Insurance Office for Salaried Workers); and the Ile-de-France Regional Health Agency (ARS). MAB’s work was funded by a Netherlands Organization for Scientific Research (NWO) VENI grant on ‘DenCityHealth: How to keep growing urban populations healthy?’ (grant 09150161810158).
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval All participating cohort studies have originally received consent from the participants and ethical approval from their respected institutions: CLSA has received ethical approval from the Hamilton Integrated Research Ethics Board. HUNT received ethical approval from the Regional Committee for Medical Research Ethics, Mid-Norway. In addition, MINDMAP-specific approval was received from the same committee. HAPIEE received ethical approval from the Joint UCL/UCLH Committees on the Ethics of Human Research, and by local ethics committees in every participating centre. RECORD received ethical approval from the Commission Nationale de l’Informatique et des Libertés. LASA received ethical approval by the Medical Ethical Committee of the Vrije Universiteit medisch centrum. Secondary use of the MINDMAP harmonised data set also received a declaration of no objection from the Medical Ethical Committee of Erasmus University Medical Centre.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement The data sets generated for the MINDMAP project are not publicly available due to study participant privacy considerations. However, data access can be requested from the individual cohort studies via the respective data access procedures in place. Data are available from the Canadian Longitudinal Study on Aging (www.clsa-elcv.ca) for researchers who meet the criteria for access to de-identified CLSA data.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.